Cresset Asset Management, LLC Novavax Inc Transaction History

Cresset Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $10,355 - $16,579	2,754 Added 5.43%	53,466 $255,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $3,360 - $5,369	700 Added 1.4%	50,712 $243,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $12,625 - $18,057	-1,854 Reduced 3.57%	50,012 $362,000
Q2 2023 Aug 14, 2023	BUY	$6.67 - $9.52 $345,946 - $493,764	51,866 New	51,866 $385,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.